Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|November 12, 2010
A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancerAthanasios Kotsakis, Sophia Agelaki, Nikolaos Vardakis, et al.
Anticancer Research|January 2, 2020
Recurrence-free Survival and Safety of Imatinib in Patients With Gastrointestinal Stromal Tumour (GIST) in GreeceIoannis Boukovinas, Athanasios Kotsakis, Nikolaos Androulakis, et al.
Anticancer Research|November 2, 2010
A retrospective analysis of non-platinum-based first- and second-line chemotherapy in patients with advanced non-small cell lung cancerAthanasios Kotsakis, Dora Hatzidaki, Lambros Vamvakas, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2006
Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II studyAlexandros Ardavanis, Dimitris Mavroudis, Kostas Kalbakis, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2011
Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001Eleni-Kyriaki Vetsika, Georgios Konsolakis, Despoina Aggouraki, et al.
Frontiers in Bioscience (Landmark Edition)|December 3, 2021
4th Summer School in Immuno-Oncology, July 1st-3rd, 2021, Athens, GreeceIoannis V Kostopoulos, Nikolaos Orologas-Stavrou, Nikolaos Angelis, et al.
Scientific Reports|March 29, 2017
TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC)Ippokratis Messaritakis, Dimitris Stoltidis, Athanasios Kotsakis, et al.
Clinical Lung Cancer|July 12, 2016
Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research GroupAthanasios Karampeazis, Lambros Vamvakas, Nikolaos Kentepozidis, et al.
Cancers|April 30, 2021
Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in "Immune Desert" NSCLCIoannis S Pateras, Athanasios Kotsakis, Margaritis Avgeris, et al.
Clinical Lung Cancer|October 18, 2011
A phase II trial of erlotinib as front-line treatment in clinically selected patients with non-small-cell lung cancerAthanasios G Pallis, Alexandra Voutsina, Nikolaos Kentepozidis, et al.
Pageof 13